Display Full Text | Download Full Text
1.04 MB PDF file

Degree

Master of Science in Biomedical Sciences (MSBS), University of Toledo Health Science Campus, Graduate School, 2005.

Abstract

Endometrial carcinoma is the most common neoplasm of the female genital tract and the fourth most common cancer in women overall. The largest risk factor for endometrial carcinoma is exposure to unopposed estrogen. In the classical pathway of estrogen activation, estrogen binds to an estrogen receptor and recruits coactivators that increase its transcriptional activity. In contrast, certain compounds known as Selective Estrogen Receptor Modulators (SERM), cause estrogen receptor to recruit corepressors that decrease its transcriptional activity. The coactivators SRC-1, SRC-2, and SRC-3 showed higher mRNA expression in the malignant tissue as compared to the benign tissue. The corepressors N-CoR and SMRT also showed increased expression in malignant endometrium. Expression levels of coregulator mRNA were highly correlated with each other as well as with progesterone receptor mRNA. There was no correlation between coregulator mRNA expression and known prognostic markers such as grade, stage, and estrogen receptor-alpha protein expression.

Subject Headings

Biology, Molecular

Keywords

Estrogen Receptor; Coactivator; Corepressor; Endometrial Cancer; Coregulator

Advisor

Brian G. Rowan, Ph.D

Pages

98p.

Document number: mco1101306830
Permalink: http://rave.ohiolink.edu/etdc/view?acc_num=mco1101306830

This ETD has been downloaded 470 times (through March 2013)